In addition, in combination with anti-PD-1 therapy, D166 demonstrated significant anti-tumor efficacy, offering promising insights and therapeutic possibilities for pancreatic cancer treatment. The gene discussed is PDCD1; the disease is familial pancreatic carcinoma.